Astex Pharmaceuticals Announces March 27th Analyst and Investor Day Agenda
DUBLIN, Calif.--(BUSINESS WIRE)--Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the Agenda for its Annual Analyst and Investor Day webcast, to take place from 10 am to 12 pm ET on Tuesday, March 27th in New York.
Investors and interested parties may access the webcast in the Investor Events section of the Company's website, www.astx.com. A webcast replay will be available for 90 days following the live event.
| 10:00 (5 min.) | Welcome and Introductions |
Timothy L. Enns |
||||
| 10:05 (15 min.) | Corporate Overview |
James S. J. Manuso, Ph.D. |
||||
| 10:20 (15 min.) | Financial Overview |
Michael Molkentin, C.P.A. |
||||
|
10:35 (15 min.)
10:50 (20 min.) |
Clinical Update
|
Mohammad Azab, M.D.
Jean-Pierre Issa, MD |
||||
| 11:10 (20 min.) | AT 13387 & HSP90 inhibitors |
Andrew Wagner, MD, PhD |
||||
|
11:30 (15 min.)
11:45 (15 min.) |
Research & Discovery
|
Harren Jhoti, Ph.D.
Martin Buckland |
||||
| 12:00 (5 min.) | Closing Remarks |
James S. J. Manuso, Ph.D. |
The times listed above are approximate and are subject to change.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed Dacogen® (decitabine) for Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.